1,676
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Psychosocial consequences among women with false-positive results after mammography screening in Norway

, , , &
Pages 380-389 | Received 21 Feb 2018, Accepted 13 Aug 2018, Published online: 08 Oct 2018

References

  • Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology. 2010;19(10):1026–1034.
  • Bond M, Pavey T, Welch K, et al. Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess (Winchester, England). 2013;17(13):1–170.
  • Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. Br J Cancer. 1990;62(6):1018–1022.
  • Cockburn J, Staples M, Hurley SF, et al. Psychological consequences of screening mammography. J Med Screen. 1994;1(1):7–12.
  • Lowe JB, Balanda KP, Del Mar C, et al. Psychologic distress in women with abnormal findings in mass mammography screening. Cancer. 1999;85(5):1114–1118.
  • Ekeberg O, Skjauff H, Karesen R. Screening for breast cancer is associated with a low degree of psychological distress. Breast. 2001;10(1):20–24.
  • Lampic C, Thurfjell E, Bergh J, et al. Short- and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer (Oxford, England: 1990). 2001;37(4):463–469.
  • Sandin B, Chorot P, Valiente RM, et al. Adverse psychological effects in women attending a second-stage breast cancer screening. J Psychosom Res. 2002;52(5):303–309.
  • Scaf-Klomp W, Sanderman R, van de Wiel HB, et al. Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community Health. 1997;51(6):705–710.
  • Aro AR, Pilvikki Absetz S, van Elderen TM, et al. False-positive findings in mammography screening induces short-term distress – breast cancer-specific concern prevails longer. Eur J Cancer (Oxford, England: 1990). 2000;36(9):1089–1097.
  • Hislop TG, Harris SR, Jackson J, et al. Satisfaction and anxiety for women during investigation of an abnormal screening mammogram. Breast Cancer Res Treat. 2002;76(3):245–254.
  • Lipkus IM, Halabi S, Strigo TS, et al. The impact of abnormal mammograms on psychosocial outcomes and subsequent screening. Psychooncology. 2000;9(5):402–410.
  • Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med. 2007;146(7):502–510.
  • Schou Bredal I, Karesen R, Skaane P, et al. Recall mammography and psychological distress. Eur J Cancer (Oxford, England: 1990). 2013;49(4):805–811.
  • Hafslund B, Espehaug B, Nortvedt MW. Effects of false-positive results in a breast screening program on anxiety, depression and health-related quality of life. Cancer Nurs. 2012;35(5):E26–E34.
  • Brodersen J, Siersma VD. Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med. 2013;11(2):106–115.
  • DeFrank JT, Barclay C, Sheridan S, et al. The psychological harms of screening: the evidence we have versus the evidence we need. J Gen Intern Med. 2015;30(2):242–248.
  • Brodersen J, McKenna SP, Doward LC, et al. Measuring the psychosocial consequences of screening. Health Qual Life Outcomes. 2007;5:3.
  • Brodersen J, Thorsen H, Cockburn J. The adequacy of measurement of short and long-term consequences of false-positive screening mammography. J Med Screen. 2004;11(1):39–44.
  • Roman M, Skaane P, Hofvind S. The cumulative risk of false-positive screening results across screening centres in the Norwegian Breast Cancer Screening Program. Eur J Radiol. 2014;83(9):1639–1644.
  • Brodersen J, Thorsen H, Kreiner S. Validation of a condition-specific measure for women having an abnormal screening mammography. ValueHealth. 2007;10(4):294–304.
  • Brodersen J, Thorsen H. Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire. Scand J Prim Health Care. 2008;26(4):251–256.
  • Brodersen J, Thorsen H, Kreiner S. Consequences of screening in lung cancer: development and dimensionality of a questionnaire. Value Health. 2010;13(5):601–612.
  • Swaine-Verdier A, Doward LC, Hagell P, et al. Adapting quality of life instruments. Value Health. 2004;7:27–30.
  • Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res. 2003;12(3):229–238.
  • Andersen E. A goodness of fit test for the rasch model. Psychometrika. 1973;38(1):123–140.
  • Kreiner S. Introduction to DIGRAM. Copenhagen: Department of Biostatistics Research, University of Copenhagen; 2003. Report No.: 03/10.
  • Bolejko A, Hagell P, Wann-Hansson C, et al. Prevalence, long-term development, and predictors of psychosocial consequences of false-positive mammography among women attending population-based screening. Cancer Epidemiol Biomarkers Prev. 2015;24(9):1388–1397.
  • Brett J, Bankhead C, Henderson B, Watson E, et al. The psychological impact of mammographic screening. A systematic review. Psychooncology. 2005;14(11):917–938.
  • Lindberg L, Svendsen M, Dømgaard M, et al. Better safe than sorry: a long-term perspective on experiences with a false-positive screening mammography in Denmark. Health Risk Soc. 2013;15(8):699.
  • Bond M, Garside R, Hyde C. A crisis of visibility: the psychological consequences of false-positive screening mammograms, an interview study. Br J Health Psychol. 2015;20(4):792–806.
  • Solbjor M, Forsmo S, Skolbekken JA, et al. Experiences of recall after mammography screening–a qualitative study. Health Care Women Int. 2011;32(11):1009–1027.